Keyphrases
Peroxisome Proliferator-activated Receptor
100%
Dorsal Horn
100%
Edema
100%
Inflammatory Pain
100%
Rosiglitazone
50%
15d-PGJ2
37%
Ligand-receptor Binding
25%
Intracerebroventricular Administration
25%
Anti-hyperalgesia
25%
Peroxisome Proliferator-activated Receptor Agonists
25%
Gene Expression
12%
Protein Expression
12%
Behavioral Effects
12%
Intrathecal Administration
12%
Receptor Antagonist
12%
Vehicle Control
12%
Peripheral Tissues
12%
Inflammatory Pathways
12%
Noxious Stimuli
12%
Motor Coordination
12%
Spinal Dorsal Horn
12%
Systemic Administration
12%
C-Fos
12%
Immediate-early Gene
12%
Fos Protein
12%
Peripheral Inflammation
12%
Intraperitoneal Administration
12%
Paw Edema
12%
Plantar
12%
Heat Hyperalgesia
12%
Peripheral Edema
12%
Inflammatory Hyperalgesia
12%
Paw Volume
12%
Carrageenan-induced Inflammation
12%
Withdrawal Response
12%
Functional Target
12%
Pain Signaling
12%
Thiazolidinediones
12%
Overt Behavior
12%
Noxious Heat
12%
GW9662
12%
Antihyperalgesic
12%
Bisphenol A Diglycidyl Ether (BADGE)
12%
Paw Thickness
12%
Direct Action
12%
Pharmacological Activation
12%
Carrageenan Model
12%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Inflammatory Pain
100%
Edema
100%
Rosiglitazone
57%
Anti-Inflammatory Drug
28%
Carrageenan
28%
Hyperalgesia
28%
PPAR Agonist
28%
Behavioral Effect
14%
Thiazolidinedione
14%
Intrathecal
14%
Systemic Administration
14%
Paw Edema
14%
2 Chloro 5 Nitrobenzanilide
14%
Peroxisome Proliferator Activated Receptor Antagonist
14%
Protein Fos
14%
Heat Hyperalgesia
14%
Inflammation
14%
Peripheral Edema
14%
Neuroscience
Peroxisome Proliferator-Activated Receptor
100%
Rosiglitazone
50%
Hyperalgesia
37%
Anti-Inflammatory
25%
PPAR Agonist
25%
Carrageenan
25%
In Vivo
12%
Behavior (Neuroscience)
12%
Intrathecal
12%
C-Fos
12%
Behavioral Effect
12%
Gene Expression
12%
Protein Expression
12%
Motor Coordination
12%
Receptor Antagonist
12%
Protein Fos
12%
Immediate Early Gene
12%
Thiazolidinedione
12%
Spinal Cord Dorsal Horn
12%